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Abstract 
Many rodent models of endometriosis are invasive, involving surgery to implant donor 
endometrial tissue into recipient animals. Moreover, few studies have compared and contrasted 
lesions between rodent strains and estrous stages without exogenous hormone manipulation. This 
is despite extensive data demonstrating that genetic and hormonal factors can influence 
endometriosis progression. Here, we have refined a minimally-invasive model of endometriosis 
using naturally cycling mice (donor and recipient matched for cycle phase) to investigate lesion 
development in two different strains (C57BL/6 and Balb/C), induced in estrous stages of high 
and low estrogen (proestrus or estrus, respectively), and with varying amounts of donor 
endometrial tissue (7.5-40 mg), injected intraperitoneally. The overall probability of developing 
endometriosis-like lesions was higher in proestrus than estrus, and increased with greater masses 
of donor tissue. Similarly, the total number of lesions (0-3) increased from 7.5 to 40 mg, and was 
significantly greater in proestrus C57BL/6 mice but not Balb/Cs. The dominant lesion type also 
differed between mouse strains; C57BL/6 mice were more likely to develop dense-type lesions, 
whereas Balb/C mice developed a greater proportion of cystic-type. This data further supports a 
role for estrogen in the development of endometriosis, and that genetic variance can influence 
the degree and characteristics of lesions. Our minimally-invasive model would be beneficial for 
studies with outcome measurements particularly sensitive to incisional injury, such as pain, or 
alterations to sex hormones, including fertility.  
Introduction 
Endometriosis is a female-specific chronic inflammatory condition, classically defined as the 
presence of endometrial-like tissue outside the uterus. Affecting an estimated 10% of women of 
reproductive age worldwide, endometriosis is highly associated with dysmenorrhea, infertility 
and persistent pelvic pain [1]. The mechanistic event underpinning the development of 
endometriosis lesions is attributed to the flow of menstrual debris through the fallopian tubes to 
the peritoneal cavity during menses (retrograde menstruation), with the subsequent implantation 
of endometrial cells [2]. However, this hypothesis cannot fully explain the pathogenesis of 
endometriosis, as approximately 90% of women aged 15-49 years will exhibit retrograde 
menstruation [3, 4], yet a much smaller proportion are at risk of developing lesions. 
Female rodents do not undergo a menstrual cycle with shedding of the endometrium akin to 
humans (with the exception of the spiny mouse [5]). Rather, an estrous cycle where the 
endometrium, in the absence of implantation, is reabsorbed by the activity of infiltrating 
leukocytes. As such, rodents will not spontaneously develop endometriotic lesions, and animal 
models to date have required manual implantation of endometrial fragments into the abdominal 
space. The vast majority of these models require surgery: either a ventral midline abdominal 
incision with uterine tissues sutured to visceral structures, such as the renowned rat autologous 
model [6, 7]; and/or a dorsal flank incision and ovariectomy, typically followed by estrogen 
supplementation [8, 9] (for reviews of rodent models used for endometriosis research see Pullen 
et al. (2011) [10] and Greaves et al. (2017) [11]).  
It is widely acknowledged that long-lasting modulation of somatosensory processing can occur 
in animals following incisional surgery or similar techniques. This includes changes in the 
sensitivity of both peripherally- and centrally-located neurons [12, 13]; altered expression of 
proteins integral to neurotransmission, such as spinal metabotropic glutamate receptors [14]; as 
well as sensitization of the neuroimmune system, demonstrated by increased reactivity of spinal 
microglia and heightened somatosensensory activity [15]. Therefore, while many studies utilize 
sham controls, subtle changes in proteins or behaviors of interest in models of endometriosis 
may be masked by a relatively larger effect of the surgery. This limits the use of available 
models for experiments that are particularly sensitive to tissue injury, such as observations of the 
nervous system (as mentioned above), and therefore may particularly impact on studies of 
peripheral and central sensitization, and pain. These investigations remain imperative, as the 
severity of pain reported by women seldom correlates with the extent and duration of 
endometriosis [16], suggesting a more complex etiology beyond that observed at the peripheral 
lesion site.  
Animal models of endometriosis that involve ovariectomy have the additional complication of 
being impracticable for studies of physiological functions that require natural fluctuations in sex 
hormones, such as fertility. It has long been hypothesized that endometriosis lesions thrive under 
the influence of heightened or prolonged estrogen stimulation [17, 18], since symptoms of the 
condition often first present at, or soon after menarche, and improve when estrogen levels fall at 
menopause; and the endometrium involutes in the absence of estrogen. Consequently, 
manipulation of sex hormones in basic scientific work has further implicated a role for estrogen 
in lesion development, where exogenous administration of estradiol in ovariectomized rodents 
enhances endometrial implant growth [19, 20]; is modulated by estrogen receptor signaling [21]; 
and can lead to recurrence of lesions that have previously regressed [22]. Researchers have also 
recently developed a hormonal protocol that transforms the rodent endometrium into a phenotype 
that mimics human menstrual debris, which is subsequently collected for use in an animal model 
[9]. Therefore, while there are many benefits of controlling sex hormones for endometriosis 
research, in many cases the continuous systemic estrogen stimulation is of supra-physiological 
levels and may not necessarily reflect the clinical setting.   
In addition to altered sex hormone activity, the variable susceptibility among human females in 
developing endometriosis lesions is also thought to be influenced by genetic (and 
environmental/epigenetic) factors [23]. Comparing lesion characteristics in rodent models of 
diverse genetic backgrounds, where the susceptibility of each strain is unknown, may complicate 
research findings. Determining the behavior of specific rodent strains may therefore provide 
further insight into the varied types of endometriosis lesions and their associated symptoms. For 
example, C57BL/6 and Balb/C are two strains of commonly used wild-type mice that are known 
to differ in their immune profiles; the former considered Th1-dominant and the latter Th2-
dominant in the immune response [24]. This affects the timing, composition and location of 
cytokine release in response to specific immune insults, and hence how each strain might 
respond to donor tissue in endometriosis models.  
Given endometriosis continues to be an area of significant unmet medical need, and the 
mechanistic disconnects between clinical presentation of the condition and animal models, we 
sought to refine and carefully characterize an animal model of endometriosis in mice. In this 
study, we have utilized a minimally-invasive, gonad intact mouse model of endometriosis which 
may be compatible with experiments that are sensitive to surgery or incisional injury, and sex 
hormone manipulation. Further, we have considered the extent of lesion development in two 
genetically diverse mouse strains, during estrous stages of relatively high and low estrogen 






Cytological evaluation of vaginal smears from 12 ± 3 week-old, virgin female mice (weighing 
20.6 ± 2.0 g) was used to determine current estrous stage, as described previously [25]. 
C57BL/6NHsd (C57BL/6; n = 43 donors and 43 recipients) or Balb/C (n = 38 donors and 43 
recipients) mice in proestrus and estrus were selected for experimental use, corresponding to the 
respective estrous stages of relatively high and low estrogen [26]. Animals were obtained from 
the University of Adelaide Laboratory Animal Services; all experimental procedures were 
performed in accordance with the National Health and Medical Research Council Australian 
code for the care and use of animals for scientific purposes (8
th
 edition, 2013) and the University 
of Adelaide Animal Ethics Guidelines, and were approved by the University of Adelaide Animal 
Ethics Committee. 
Induction of endometriosis 
Donor mice were anesthetized by isoflurane inhalation, sacrificed by cervical dislocation and 
their uterus removed. Tissues were placed immediately in cold (4°C) phosphate-buffered saline 
(0.01M PBS composed of 13.7mM NaCl, 0.27mM KCl, 0.15mM KH2PO4 and 0.8mM 
Na2HPO4; pH 7.4) in a glass petri dish. Residual connective tissue, fat, the ovaries and cervix 
were removed, and each horn was opened along the mesometrial border. The uterine horns were 
then pinned flat to the Sylgard-coated base (Dow Corning; Michigan, USA) of the glass petri 
dish using entomology pins. The endometrium was removed by sharp dissection, measured for 
wet weight, and sectioned into 2-3 mm
2
 fragments. Once the desired amount of endometrium 
was collected (7.5, 15, 25 or 40 mg), the fragments were suspended in a syringe with 0.5 ml 
sterile saline (0.9% NaCl; RT) and passed once through a 21-gauge needle. This was to ensure 
smooth delivery of content to recipient animals.  
Recipient mice of syngeneic strain and identical estrous stage were then intraperitoneally 
injected with the donor endometrial fragment suspension (ENDO mice) at the ventral midline 
between the left inguinal nipples. Control recipient mice were injected with an equal volume of 
sterile saline only. Following 21 days development, ENDO mice were deeply anesthetized with 
isoflurane gas and decapitated, to allow for an unobstructed view of the abdominopelvic cavity. 
After thorough examination, the number and location of endometriosis-like lesions was recorded. 
Identified lesions and control tissues for histological comparison from saline-injected mice 
(endometrium, lymph nodes, gastrointestinal tract, fat) were immediately fixed with cold (4°C) 
paraformaldehyde fixative (4% in 0.01M PBS; pH 7.2) for 4-6 hours.  
Histological Assessment 
Endometriosis-like lesions and control tissues were further fixed in 10% neutral-buffered 
formalin (Chem-Supply; South Australia, Australia) overnight (4°C), placed in cassettes and 
submerged into 70% ethanol, then dehydrated in graded alcohols, cleared with xylene, and 
embedded with warmed liquid paraffin wax. Once solidified, serial sections of 5 μm were cut 
using a rotary microtome and collected onto albumin-coated slides. Routine hematoxylin and 
eosin staining was then performed, and the slides scanned using a NanoZoomer (Hamamatsu 
Photonics; Shizuoka Pref., Japan) and viewed with NanoZoomer Digital Pathology software 
view.2 (Histalim; Montpellier, France). Lesions were assessed in a blinded fashion for the 
presence of both glands and stroma, which are typically prerequisite for a confirmed diagnosis of 
endometriosis in humans [27]. Parameters including inflammatory cell infiltration, blood vessels, 
connective tissue and the presence of cysts were also recorded. Immunohistochemical staining 
for F4/80 was performed to further confirm the presence of macrophages within endometriosis-
like lesions (for details see Supplementary Figure 1). Only lesions classified as dense- or cystic-
type were counted toward the total number of lesions obtained from an ENDO animal (see 
Results section (1) below). The size of endometriosis-like lesions was defined in this study as the 
maximum diameter of the cut surface area in histological sections. Note that due to their variable 
shape, lesions were orientated during embedding so that the greatest dimension would be 
sectioned longitudinally.  
Statistical analysis 
In total, 14 experimental groups were analyzed: C57BL/6 and Balb/C mice in proestrus injected 
with 7.5, 15, 25 and 40 mg donor endometrial tissue (8 groups proestrus); and C57BL/6 and 
Balb/C mice in estrus injected with 15, 25 and 40 mg endometrium (6 groups estrus).  
SPSS Statistics 24 software (IBM; New York, USA) was used for statistical analyses and 
GraphPad Prism 7 software (GraphPad Software Inc.; California, USA) was used to generate 
figures. A logistic regression model was used to investigate the association of at least one lesion 
present (lesion success) with the mouse model variables; a linear regression model and two-way 
ANOVA with Holm-Šídák multiple comparisons were performed to assess for associations 
between the total number of lesions, after determining that the assumptions of a linear model 
were upheld; a logistic generalized estimating equation model was performed to analyze the 
associations between lesion type (cystic or dense) as well as lesion locations; and a linear mixed-
effects model was used to determine differences in lesion sizes.  
The independent variables in these statistical models were mouse strain (C57BL/6 or Balb/C), 
estrous stage at induction (proestrus or estrous) and mass of injected tissue (7.5, 15, 25 or 40 
mg), which were analyzed individually or with strain-stage, stage-mass or mass-strain 
interactions. From the statistical models, an odds ratio or estimate, 95% confidence interval, 
comparison P value and interaction P value (where applicable) were calculated. A P value of 
<0.05 was considered statistically significant. Values are presented as mean ± standard deviation 
in Results section (1) and mean ± standard error for sections (2-5). 
Results 
1. Endometriosis-like lesions develop with distinct characteristics 
Endometriosis-like lesions were successfully established in our minimally-invasive mouse 
model. No interruptions to the estrous cycle were observed in recipient ENDO mice throughout 
the 21-day development period, indicating that the ovaries were intact and functioning as normal. 
The 7.5 mg recipient group were injected with an average of 7.6 ± 0.2 mg donor endometrium in 
5.1 ± 0.3 pieces (n = 12); the 15 mg ENDO animals 16.3 ± 1.2 mg in 9.0 ± 1.5 pieces (n = 26); 
the 25 mg group with 25.0 ± 2.4 mg in 18.5 ± 4.0 pieces (n = 24); and 40 mg ENDO animals 
41.1 ± 2.3 mg in 28.8 ± 3.5 pieces (n = 24). No overt effects were observed on the reproductive 
organs or tissues adjacent to endometriosis-like lesions in ENDO mice, except for occasional 
areas of erythema surrounding the lesions. Following histological processing and imaging, all 
endometriosis-like lesions collected from ENDO mice were initially classified into one of three 
categories based on their characteristics: dense, cystic or necrotic-type lesions.  
Macroscopically, dense-type lesions appeared opaque and light pink to deep red in color with a 
smooth surface, in some cases speckled with darker red blood vessels, and ranged from 221 to 
4260 µm in length (average lesion length 1219 ± 832.8 µm; n = 45) (Fig. 1A). On histological 
inspection it was confirmed that dense lesions contained both epithelial (glandular) and stromal 
endometrial cells (Fig. 1D). These lesions were encapsulated by a sheath of connective tissue, 
vascularized with single-layer walled small blood vessels, and commonly infiltrated by 
inflammatory cells, such as macrophages and lymphocytes (identified by their morphological 
characteristics). Identified macrophages often contained areas of punctate brown staining akin to 
hemosiderin deposition, as has been observed in other animal models[28] and human 
endometriosis lesions[29]. 
Cystic-type lesions were characterized by the presence of a fluid-filled cyst in addition to 
endometrial glands and stroma. Cystic lesions were again light pink in color although translucent 
due to the cysts; in many cases the donor endometrial fragments could be seen inside. The cysts 
often had a “bubbled” or multi-lobed appearance (Fig. 1B, E). These lesions were commonly 
surrounded by a capsule of connective tissue that appeared contiguous with adjacent structures. 
Cystic-type lesions were also vascularized, and displayed inflammatory cell infiltrate within the 
stroma (Fig. 1E-a). Cysts typically contained inflammatory cells (including macrophages and 
lymphocytes) and red blood cells (Fig. 1E-b), as well as a yet-unidentified lightly eosinophilic 
web-like structure (Fig. 1E-c). The presence of macrophages in lesions was further confirmed by 
distinct F4/80-positive structures within the cyst lumen and stroma (Supplementary Figure 1). 
Cystic-type lesions were generally larger than dense lesions, ranging from 503 to 3700 µm 
(average 1990 ± 847.1 µm; n = 50).  
Necrotic lesions were ubiquitously white in color with an irregular surface, and small in size 
(range 564 to 650 µm; average 606.5 ± 35.87 µm; n = 4) (Fig. 1C). Histologically they were 
defined by a majority presence of necrosis within a lesion, determined as areas of dense 
hematoxylin staining without discernible cellular or tissue structure (Fig. 1F). This meant that in 
many necrotic lesions obvious glands and stroma were not identified. Interestingly, necrotic 
lesions were only observed in ENDO animals induced with proestrus endometrial tissue. Due to 
the single time-point of tissue collection in this study, it is unknown whether necrotic lesions 
were previously fully formed lesions that were degenerating at the time of collection, or if they 
never formed lesions and were deteriorating donor endometrial tissue left over from the initial 
ENDO injection. For these reasons, and that glands and stroma were not consistently present, 
necrotic-type lesions were excluded from further analysis.  
2. Endometriosis lesions develop in diverse peritoneal locations 
The location of endometriosis-like lesion development was random across the various ENDO 
groups; there were no significant associations with estrous stage, mass of injected tissue, or strain 
of mouse. Lesions formed in several locations within the peritoneal cavity, typically on the 
anterior surfaces; likely because of the posture and gravity in quadrupedal animals. Most often 
lesions tended to form on connective tissue-like structures, such as mesenteric attachments 
between the stomach and pancreas (47/95 lesions; 49.5% total). It was common to also observe 
lesions on the anterior abdominal wall, at a level typical of the injection site (18/95 lesions; 
18.9% total), as well as within fatty structures such as the gonadal white adipose tissue (24/95 
lesions; 25.3% total) (Fig. 2). Few lesions (3/95 lesions; 3.1% total) formed in the subcutaneous 
space, likely due to residual fragments of endometrial tissue embedding at the insertion point 
upon needle withdrawal. A single lesion also formed on connective tissue anchoring the 
descending colon to the posterior abdominal wall (1.1% total), and two lesions were found on 
connective tissue bridging the posterior uterine body with the anterior descending colon/rectum 
(2.1% total).  
3. Successful development of endometriosis-like lesions is dependent on the quantity of 
donor endometrium and estrous stage at induction 
Controlling for both mouse strain and stage, the incidence of endometriosis-like lesion 
development increased as the amount of donor endometrial tissue injected into ENDO mice 
progressed from 7.5 to 40 mg. Collectively amongst the ENDO groups, the rate of lesion 
establishment was 33.3% for animals injected with 7.5 mg (n = 4/12); 69.2% for 15 mg animals 
(n = 18/26); 83.3% for those in the 25 mg group (20/24); and 100% for recipient mice injected 
with 40 mg endometrium (n = 24/24). Using the 7.5 mg group as reference (14% estimated 
probability of developing lesions), 15 mg ENDO animals were 16.9 times more likely to develop 
lesions (73% probability; P = 0.004), 48.5 times more likely with 25 mg (88% probability; P = 
0.001), and were all expected to develop lesions in the 40 mg group (100% probability; P 
<0.001).  
Interestingly, endometriosis-like lesions were 1.9 times more likely to establish in proestrus as 
opposed to estrus (P = 0.009), when controlled for both strain and group mass. For C57BL/6 
ENDO mice, lesions were observed in 33.3% (n = 2/6) of animals injected with 7.5 mg tissue in 
proestrus, and in all animals with 15 mg and above (100%; 19/19). Balb/C mice in proestrus 
developed lesions in 33.3% of 7.5 mg animals (n = 2/6), 71.4% of 15 mg animals (n = 4/7), and 
100% of animals injected with 25 and 40 mg of donor endometrial tissue (n = 12/12) (Fig. 3A). 
In contrast, lesions developed in only half of 15 mg C57BL/6 and Balb/C ENDO mice in estrus 
(50%; n = 3/6 per strain), two-thirds of 25 mg mice (66.7%; n = 4/6 per strain) and all animals at 
40 mg (100%; n = 6/6 per strain) (Fig. 3B). ENDO animals in estrus with 7.5 mg donor tissue 
were not analyzed in this study.  
No mouse strain effect was observed for the successful development of lesions. The incidence of 
lesion development was equal in both C57BL/6 and Balb/C mice, except at 15 mg in proestrus 
where C57BL/6 ENDO mice had a slightly increased rate (by 28.6%) compared to Balb/Cs 
(100% vs. 71.4% respectively; 95% CI: -0.05, 0.62).   
4. The total number of endometriosis-like lesions developed by ENDO mice is modulated by 
quantity of donor endometrium, estrous stage at induction and mouse strain 
In addition to the frequency of ENDO animals developing lesions, there was a positive 
correlation between the number of total endometriosis-like lesions per animal and the mass of 
donor endometrium. Controlled for strain and stage, animals injected with 7.5 mg tissue 
developed 0-1 lesions (mean 0.13 ± 0.21); 15 mg animals 0-2 lesions (mean 0.79 ± 0.13); 25 mg-
injected animals 0-3 lesions (mean 1.25 ± 0.14); and 40 mg animals 1-3 lesions (mean 1.67 ± 
0.14) (all pairwise comparisons P ≤0.033). 
In C57BL/6 ENDO mice, a greater total number of lesions per animal were observed in the 
proestrus groups as opposed to estrus groups. On average 7.5 mg proestrus mice developed 0.33 
± 0.24 lesions; 15 mg mice developed 1.14 ± 0.22 lesions in proestrus versus 0.50 ± 0.24 lesions 
in estrus; the 25 mg proestrus group developed 1.67 ± 0.24 lesions versus 0.67 ± 0.24 lesions in 
estrus; and the 40 mg groups developed 1.67 ± 0.24 versus 1.50 ± 0.24 lesions, respectively. 
Therefore overall, proestrus C57BL/6 mice had a probability of developing 0.60 ± 0.21 more 
lesions at any given group mass compared to those in estrus (P = 0.005), with the most 
significant difference at 25 mg (probability of 1.00 ± 0.34 more lesions in proestrus than estrus; 
P = 0.004) (Fig. 4A). This is reiterated by a reduced average mass of endometrium that was 
required to obtain 0 (7.68 ± 0.11 vs 19.66 ± 2.07 mg; P = 0.004), 2 (22.03 ± 3.25 vs 37.97 ± 0.62 
mg; P = 0.017) and 3 lesions (34.77 ± 5.84 vs >40 mg) in proestrus versus estrus, respectively 
(Fig. 4B). The pattern for the predicted number of lesions per group mass in proestrus was an 
increase by 0.81 ± 0.33 lesions from 7.5 mg to 15 mg (P = 0.014), which then remained stable at 
25 mg (+ 0.52 ± 0.33 lesions from 15 mg to 25 mg; P = 0.113) and 40 mg (+ 0.00 ± 0.34 lesions 
from 25 mg to 40 mg; P = 1.000). In estrus, the 15 mg and 25 mg groups developed similar 
numbers of lesions (+ 0.17 ± 0.34 lesions from 15 mg to 25 mg; P = 0.627) until 40 mg, which 
showed an increase by 0.83 ± 0.34 lesions (from 25 mg; P = 0.015). 
In contrast, Balb/C ENDO mice developed similar total numbers of lesions per group mass 
regardless of estrous stage (Fig. 4C). For 7.5 mg animals in proestrus, the average number of 
lesions was 0.33 ± 0.29; 15 mg mice developed 1.00 ± 0.26 lesions in proestrus versus 0.86 ± 
0.28 lesions in estrus; the 25 mg proestrus group developed 1.50 ± 0.26 lesions versus 1.60 ± 
0.23 lesions in estrus; and the 40mg groups developed 2.33 ± 0.21 versus 1.89 ± 0.24 lesions, 
respectively. Again, the absence of separation between proestrus and estrus is shown by similar 
average quantities of endometrium used to produce 1, 2, and 3 lesions (0 lesions 9.24 ± 2.32 vs 
19.72 ± 2.27 mg, respectively; P = 0.032) (Fig. 4D). The predicted number of lesions per group 
mass in proestrus did not significantly differ when compared incrementally until 40 mg, with an 
estimated 0.83 ± 0.33 more lesions than at 25 mg (P = 0.013). Although no differences were 
observed from 7.5 mg to 15 mg and then 15 mg to 25 mg, overall the 25 mg group was likely to 
develop 1.17 ± 0.39 lesions more than at 7.5 mg (P = 0.003) indicating a steady increase in 
lesion number throughout this range. In estrus, the predicted number of lesions increased from 15 
mg to 25 mg (increase by 0.74 ± 0.36; P = 0.039) that remained stable from 25 mg to 40 mg 
(increase by 0.29 ± 0.34; P = 0.390). Between the 15 mg to 40 mg groups lesions were estimated 
to increase by 1.03 ± 0.37 (P = 0.005).  
5. Endometriosis-like lesion characteristics differ between mouse strains 
A total of 95 lesions were collected from ENDO animals, 50 of which were cystic (52.6%) and 
45 classified as dense-type (47.4%). No differences in the ratio of cystic-to-dense lesions were 
detected in proestrus versus estrus (P = 0.186), where there were 33 (56.9%) cystic and 25 
(43.1%) dense lesions in proestrus, versus 17 (45.9%) cystic and 20 (54.1%) dense lesions in 
estrus (Fig. 5A). Similar proportions of the lesion types were also observed across the group 
masses (all pairwise comparisons P ≥0.172). ENDO mice with 7.5 mg donor tissue developed a 
total of 2 cystic and 2 dense lesions (50% each); 15 mg animals had 12 (57.1%) cystic and 9 
(42.9%) dense lesions; 25 mg animals developed 13 (43.3%) cystic and 17 (56.7%) dense 
lesions; and finally 40 mg ENDO animals developed 23 (57.5%) cystic and 17 (42.5%) dense 
lesions (Fig. 5B). However, Balb/C mice were 2.7 times more likely to develop cystic versus 
dense lesions compared to C57BL/6 mice (P = 0.022). From Balb/C mice a total of 31 (63.3%) 
cystic and 18 (36.7%) dense lesions were collected, whereas C57BL/6 mice developed 19 
(41.3%) cystic and 27 (58.7%) dense lesions (Fig. 5C).  
Adjusted for mass and strain, the average diameter of endometriosis-like lesions in proestrus was 
1.42 ± 0.14 mm and in estrus 1.32 ± 0.18 mm (P = 0.573) (Fig. 6A). Lesions from animals 
receiving 7.5 mg donor endometrium were 0.86 ± 0.44 mm in size; 15 mg animal lesions 1.43 ± 
0.19 mm; 25 mg animal lesions 1.33 ± 0.16 mm; and 40 mg animals had lesions 1.86 ± 0.14 mm 
in size. Statistically, lesions from the 40 mg group were 1.00 ± 0.46 mm larger than those from 
7.5 mg animals (P = 0.033) and 0.53 ± 0.21 mm larger than 25 mg animals (P = 0.013) (Fig. 6B). 
Moreover, C57BL/6 mice developed lesions 1.22 ± 0.16 mm in size and Balb/C mice 1.52 ± 0.60 
mm (P = 0.104) when controlled for mass and stage (Fig. 6C). Post-hoc analysis interestingly 
revealed that within the 40 mg group there was a significant difference in lesion size between the 
mouse strains, where those from Balb/C ENDO mice were estimated to be 0.72 ± 0.27 mm larger 
than in C57BL/6 animals (P = 0.010) (Fig. 6D). This difference is most likely due to the greater 
numbers of cystic-type lesions that were developed by Balb/C over C57BL/6 ENDO mice, and 
that cystic lesions were typically larger than dense lesions.  
Discussion 
In this study, we have carefully characterized the expression of endometriosis-like lesions in a 
minimally-invasive, hormonally intact mouse model. Akin to the human condition, lesions were 
phenotypically heterogeneous; the vast majority presenting with well-organized endometrial 
glands and stroma, with or without cysts. Lesions were also of variable size, and adhered to a 
number of visceral structures within the peritoneum. We have demonstrated that viable lesions 
were able to form both without using surgical procedures, or any exogenous sex hormone 
administration to either donor or recipient animals. In addition, our data shows distinct patterns 
in lesion development dependent on the estrogen status, mouse strain, and mass of endometrial 
tissue injected.  
Location of endometriosis-like lesion development is indiscriminate  
The anatomical locations of lesions within the abdominopelvic cavity of ENDO mice did not 
form any discernible pattern, using the model permutations investigated in this study. Most 
lesions adhered on superficial peritoneal locations anywhere from the diaphragm to pelvis, as a 
result of posture and gravity in quadrupedal mice. This is in opposition to humans, where the 
majority of lesions are typically distributed deeper within the pelvis due to the influence of a 
bipedal gait [30].  
Regardless, the visceral tissues which lesions adhered to appeared similar to those observed in 
humans, with the exception that lesions did not form on the surfaces of the visceral organs. Most 
commonly, lesions established on the peritoneum and connective tissues around the stomach, 
with occasional lesions associated with the colon and uterus. These structures may resemble 
connective tissues within the female pelvis where endometriosis is frequent, including the 
uterosacral ligaments and the rectouterine pouch [31, 32]. The affected locations in our ENDO 
mice have also been described in models by other laboratories [9, 21]. Thus, both the phenotypic 
characteristics and anatomical distribution of lesions in our minimally-invasive mouse model of 
endometriosis appear to be valid for its use in future investigations.  
Prevalence and total number of endometriosis lesions increases with greater endometrial 
debris 
As mentioned, the mechanical event believed to underpin the development of endometriosis is a 
retrograde menstruation, with the subsequent deposition, attachment and growth of endometrial 
fragments within the abdominopelvic cavity. In order to replicate this process in rodent models, 
including the method used in this study, endometrial fragments are administered by 
intraperitoneal injection. We observed that endometriosis-like lesions were more likely to 
develop in our ENDO animals as the amount of injected donor endometrium increased. In 
addition to the success rate, the total number of lesions also increased with greater doses of 
tissue.  
This indicates that in our model we can reasonably predict the success and number of lesions that 
will develop depending on the amount of donor tissue injected (i.e. dose-dependency). These 
results correlate with clinical observations, where it is consistently reported that, proportionally, 
endometriosis patients have earlier age of menarche, shorter menstrual cycle lengths, heavier 
menstrual effluent, and increased duration of menstrual flow than control counterparts [33, 34]; 
all characteristics that may contribute to large and frequent volumes of retrograde menstruation. 
Under normal conditions, refluxed endometrial debris is primarily cleared from the peritoneum 
by cells of the immune system. However, greater volumes of menstrual debris are hypothesized 
to overwhelm the peritoneal macrophage clearing mechanism, resulting in a permissive 
environment for developing endometriosis. Hence, one of the current successful therapies for 
preventing the recurrence of endometriosis is to suppress endometrial growth and menstruation 
(usually by hormonal manipulation, such as levonorgestrel [35]), thereby reducing the volume of 
menstrual debris for retrograde transport into the abdominopelvic cavity.  
We also found that lesions developed from the greatest endometrial mass administered (40 mg) 
tended to be larger in size compared to those from smaller injections (7.5 and 25 mg). It may be 
speculated that administration of larger quantities of endometrial fragments challenges the 
immune clearance system to such an extent that the response mounted is insufficient and thus the 
lesions that establish consequently grow larger in size. In any case, the dose-response nature of 
our model may be vital for future studies investigating the effects of interventions on total lesion 
number, and supports that the quantity of injected endometrial tissue must be considered when 
comparing results between laboratories. Additionally, this flexible dosing approach allows for 
exploration of the signaling factors derived from the endometrial tissue that may condition the 
environment for endometriosis-like lesion development. 
 
 
Endometriosis lesions are more likely to develop under conditions of naturally high estrogen 
The endometrium is one of the primary targets for sex hormone stimulation, with estrogen 
producing many biological effects including hyperplasia, hypertrophy and vascularization, and 
therefore favorable for the development of endometriosis lesions. While not wholly necessary for 
lesion establishment [21], administration of exogenous estrogen has been demonstrated in 
numerous studies to augment the total number, size, adherence, and invasiveness of lesions and 
promote tissue integrity [19, 21, 36].  
Here, we are the first to investigate the effect of natural fluctuations in estrogen in freely cycling 
mice on the development of endometriosis, by inducing the condition during estrous stages of 
proestrus (pre-ovulation; higher estrogen) and estrus (post-ovulation; lower estrogen). Other 
laboratories using naturally cycling rodents typically use estrus [37] or diestrus endometrium 
[38, 39] (the latter hormonally comparable to menses in humans) and/or administer exogenous 
estrogen at least to the donor animal regardless of estrous stage [40]. Endometriosis-like lesions 
in this study were achieved at a significantly higher rate during proestrus than in estrus, 
irrespective of mouse strain or volume of donor tissue. C57BL/6 mice also developed a greater 
total number of lesions in proestrus, although no other differences in lesion characteristics such 
as size, type or location were found to be dependent on estrous stage.  
Thus, our data shows that several previous experimental observations of endometriosis can be 
replicated in rodent models without the use of additional hormones. In addition, we further 
support a role for estrogen in enhancing susceptibility to lesion formation. That we did not 
observe other estrous-dependent variations in lesion characteristics likely relates to a limitation 
of our minimally-invasive mouse model, which is that the inoculated donor endometrium was 
healthy. In addition, the tissue was not menstrual-like [9] nor at an equivalent estrous stage to the 
menstrual phase in humans [38], as our aim was to characterize lesion development using 
endometrium influenced by natural periods of low and high estrogen. While we were able to 
positively identify endometriosis-like lesions generated from such tissue, considerable evidence 
from studies on human lesions and eutopic menstrual tissue from endometriosis patients has 
shown to be atypical compared to healthy endometrium.  
One of the major purported differences is that the endometrium from women with endometriosis 
may be functionally resistant to progesterone stimulation [41]. The failure of progesterone to act 
appropriately ultimately affects the phenotype of endometrial tissue shed at menstruation, which 
displays a prolonged reduction in anti-inflammatory signaling, and highly robust, pro-growth 
endometrial debris under mostly estrogenic stimulation [42]. Therefore, while the donor tissue 
used in our model may not fully mimic the endometrial characteristics observed in endometriosis 
patients, it does not preclude from using donor tissues in future studies that more accurately 
represent the pathophysiology of lesion development in humans.   
Quantity and characteristics of endometriosis lesions differ between mouse strains of diverse 
genetic backgrounds 
Another novelty of the present study is that we comprehensively compared and contrasted the 
development of endometriosis-like lesions in two genetically diverse, wild-type inbred mouse 
strains. Using a surgical model with estrogen supplementation, only one study to our knowledge 
has investigated lesion formation in similar mice, which reported no strain differences in their 
number or histological characteristics in recipients with a maximum 15 mg donor tissue [43]. 
These experimental conditions would most closely resemble our 15 mg proestrus group. 
Considering this permutation alone, we would also be unable to discern any variations in lesion 
number or characteristics between the mouse strains. However, when analyzed in combination 
with greater volumes of endometrium and at different estrous stages, several critical differences 
were established.   
C57BL/6 mice generated a significantly greater total number of lesions in proestrus than estrus; 
an effect that was not observed in Balb/Cs. Based on the previous information linking sex 
hormones and endometriosis, the higher lesion count in proestrus C57BL/6 mice likely also 
reflects the effects of relatively high estrogen levels at induction (and therefore a pro-survival, 
pro-growth, pro-vascularization microenvironment surrounding the endometrial debris). It was 
unexpected, and unknown at this stage why Balb/C mice did not show a similar cycle-sensitivity.  
As speculated, mouse strain differences in the development of endometriosis lesions could be 
attributed to variations in their immune responses to the donor endometrial tissue. In addition to 
an excess of refluxed menstrual debris, dysregulation of peritoneal macrophage function has also 
been implicated in the implantation and growth of endometrial lesions [44]. The specific 
mechanisms contributing to the evasion of ectopic endometrium from immune clearance are 
vast, and include decreased cell cytotoxic activity [45]; altered levels of pro-inflammatory 
cytokines, growth and angiogenic factors [46]; decreased recognition of ectopic endometrium 
[47]; and increased immune cell apoptosis [48] (for reviews see Christodoulakos et al. (2007) 
[49]; Herington et al. (2012)[44]).  
Although immune responses of the wild-type mice used in this study may not necessarily have 
been inappropriate, their different genetic regulation may result in activation of distinct 
inflammatory cells, signaling cascades and mediators that ultimately determines the fate of the 
endometrial debris. Previous studies have demonstrated that C57BL/6 and Balb/C mice exhibit 
strikingly different cytokine signatures to several bacterial infections [50, 51]; show estrous 
cycle-dependent [52] and brain region-specific [53] inflammatory responses to an identical 
stimulus; and are diversely susceptible to experimental autoimmune conditions [54], and 
tumorigenesis [55, 56].  
In general, C57BL/6 mice are genetically inclined to mount a Th1/M1 macrophage-dominant 
immune response, characterized by an IFNγ-mediated upregulation of multiple pro-inflammatory 
mediators such as TNFα, IL-1β, IL-6 and iNOS.  Balb/C mice alternatively produce Th2/M2 
macrophage-dominant responses, an IL-4-driven milieu of anti-inflammatory cytokines, 
including IL-5, IL-8 and IL-10 [57, 58]. A previous study showed that adoptive transfer of M1 
macrophages into the peritoneum of recipient mice resulted in significantly reduced growth of 
endometriosis-like lesions, while conversely enhanced growth in the presence of M2 
macrophages [59]. A similar phenomenon could therefore be associated with the opposing 
predominant lesion types observed here, where C57BL/6 mice (Th1/M1) developed more lesions 
with small dense-type characteristics, as opposed to the large cystic-type in Balb/Cs (Th2/M2).  
Our findings highlight that caution should be taken when translating results between different 
strains of mice (and between species), and to carefully consider strain prior to the initiation of 
new experiments. Given that macrophages from peritoneal fluid and ectopic lesions in 
endometriosis patients express higher levels of M2 markers [59], we suggest that Balb/C mice 
may be a preferred mouse strain that more closely represents the human condition (and therefore 
better suited for human xenograft mouse models), although further investigations are necessary. 
Future studies conducting screening of novel pharmacological interventions should consider 
conducting tests in multiple strains to avoid unfortunate false-negative results. Additionally, 
these data point to the need for personalized medicine in the treatment of endometriosis through 
phenotyping of the lesion types and targeted treatment selection. 
 Conclusions 
As with all rodent models of endometriosis, the absence of natural menstruation means that care 
must be taken when translating research to humans. Nevertheless, it is hoped that the minor 
interventions required to successfully develop lesions in this study may be particularly beneficial 
for researchers investigating endometriosis-induced alterations to the CNS, reproductive 
processes or any other biological system that is sensitive to surgery or the manipulation of sex 
hormones. Examples of potential applications include maternal or early life influences of lesion 
development, the impact of surgical removal of lesions, contributions to and consequences of 
pain and central sensitization, and the effect of lesions on fertility. With such possibilities, this 
model may be useful for studying new molecular targets and therapeutics, to ultimately provide 
better treatment outcomes for women often long-suffering with endometriosis.  
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Figure 1. Macroscopic and histological characteristics of endometriosis-like lesions developed in the 
minimally-invasive mouse model of endometriosis (ENDO). (A) Macroscopic image of a dense-type 
lesion embedded within gonadal white adipose tissue. The lesion is opaque and pink-red colored, and the 
surface is generally smooth; note connective tissue strand adhering the anterior surface of the lesion to an 
adjacent region of fat. (B) Cystic-type lesions had a “bubbled” appearance and were often translucent. (C) 
Necrotic-type lesions were easily identified by their striking white color and small size. (D) Histological 
example of a dense-type lesion, showing the connective tissue capsule (CT), endometrial glands (G) and 
endometrial stroma (S). (E) Cystic-type lesions contained one or more fluid-filled cysts (Cy). Within the 
stroma (E.a, inset) and cysts (E.b, inset), macrophages (arrowheads) often stained brown within their 
cytoplasm, indicating possible hemosiderin deposition. (E.c, inset) Cysts also contained a lightly 
eosinophilic web-like structure with sporadic nuclei of an unidentified cell type. (F) Necrotic-type lesions 
showed areas of hematoxylin-rich tissue necrosis (N), with minimal discernible endometrial glands or 
stroma. Magnification in (E.a-c) 40x inset.  
 
Figure 2. Anatomical locations of endometriosis-like lesions established in ENDO mice. (A) 
Schematic diagram of the anterior view of the internal female mouse anatomy, depicting the 
locations of endometriosis-like lesions established in ENDO mice. Commonly, lesions were 
found most superiorly on connective tissue attachments near the stomach and pancreas, on the 
anterior abdominal wall (ipsilateral to the injection site), and inferiorly within the gonadal white 
adipose tissue. Few lesions formed in the subcutaneous space (also ipsilateral to injection), on 
connective tissue of the colon, and connective tissue between the colon and uterus. (B) 
Summarized data of the proportion of lesions in each location. Outline of mouse anatomy in (A) 
adapted with permission from Elsevier and Jackson Laboratories[60].  
 
Figure 3. Modulation of endometriosis-like lesion prevalence in ENDO mice by the 
quantity of donor endometrium and estrous stage at induction. (A) Proportion of C57BL/6 
and Balb/C ENDO animals in proestrus, grouped by mass of donor endometrial tissue, which 
developed at least one endometriosis-like lesion three weeks post-injection. (B) Proportion of 
animals that successfully established lesions when induced in estrus. Overall, the probability of 
lesion development increased as the mass of donor endometrial tissue increased (statistics not 
shown), and was also greater in proestrus (high estrogen) than estrus (low estrogen). However, 
there was no effect of mouse strain on lesion establishment. ** denotes P <0.01.  
 
Figure 4. Total number of endometriosis-like lesions developed by ENDO mice is 
influenced by mouse strain, estrous stage, and mass of injected donor endometrial tissue. 
(A) Summarized data showing the proportions of total endometriosis-like lesions (0-3) 
developed by C57BL/6 mice in proestrus and estrus, at each mass of injected endometrial tissue. 
With increasing amounts of donor endometrium, more lesions established and, interestingly, a 
greater total number of lesions developed in proestrus compared to estrus (particularly at 25 mg). 
(B) This is supported by data displaying the average amount of endometrial tissue required to 
produce a given number of lesions. Here, the histogram indicates that to generate 0, 2 or 3 
lesions proestrus C57BL/6 mice required less donor endometrial tissue compared to those in 
estrus. (C) While the total number of lesions was also greater with increased tissue mass in 
Balb/C mice, there was no statistical difference between the estrous stages. (D) A comparison 
between tissue volume and lesion number further indicates little effect of estrous stage 
influencing lesion number in Balb/C mice (except for 0 lesions). As indicated by the dashed lines 
linking the average mass of tissue per lesion number, note the similar patterns of lesion 
development between proestrus C57BL/6 mice in (B) and estrus Balb/C mice in (D), and visa 
versa. Bars not sharing the same superscript within the same panel are statistically different (P 
<0.05). Uppercase letters are used for analysis within proestrus only, and lowercase letters are 
used for analysis within estrus. * denotes P <0.05; ** P <0.01; # no lesions developed for 
statistical comparison. 
 
Figure 5. Probability of lesion type is altered in C57BL/6 and Balb/C ENDO mice. (A) 
Proportion of lesions characterized as cystic or dense-type were similar in proestrus (n = 58 
lesions from 40 animals) and estrus (n = 37 lesions from 26 animals). (B) Lesion type did not 
differ amongst different group masses (7.5 mg n = 4 lesions from 4 animals; 15 mg n = 19 
lesions from 18 animals; 25 mg n = 30 lesions from 20 animals; and 40 mg n = 40 lesions from 
24 animals). (C) There was a significant difference in the ratio of cystic-to-dense lesions 
between the C57BL/6 (n = 46 lesions from 34 animals) and Balb/C mouse strains (n = 49 lesions 
from 32 animals). Balb/C ENDO mice were 2.7 times more likely to develop cystic-type lesions 
than C57BL/6s. * denotes P <0.05.  
 
Figure 6. Maximal diameter of endometriosis-like lesions varied with mass of injected 
tissue and mouse strain. (A) The average size of lesions was similar regardless of estrous stage 
at the time of endometriosis induction. (B) However, lesions tended to be larger in animals 
injected with 40 mg donor endometrial tissue compared to the 7.5 mg and 25 mg groups. (C) 
While overall there was no difference in the size of lesions between the two mouse strains, at 40 
mg only (D) lesion diameter was greater in Balb/C ENDO mice compared to C57BL/6s. * 
denotes P <0.05. 
 
